Darnitsa - the Leader in Sale of Medicinal Products15 March 2018
Based on the results of the year 2017, the Pharmaceutical Firm Darnitsa confirmed its status of the leader in sale of medicinal products in Ukraine in volume terms. According to the retail audit of the Market Research System of Proxima Research, the first place in the segment has been held by Darnitsa for already more than 10 years.
The volume of sales of medicinal products in Ukraine in 2017 in Ukraine amounted to 1.1 billion packs, what is by 6.5% more than in 2016. Therewith, the market share of “Darnitsa” in volume terms in 2017 amounted to 15.0%. It means that every 7th pack of medicinal products on shelves of pharmacies is produced by the Pharmaceutical Firm Darnitsa.
9 medicinal products from the company’s product portfolio are leaders in the market in place No. 1 based on the results of the year. More specifically, “Citramon-Darnitsa” in 2017 took the lead in the category of drugs for headache in volume and in money terms. Moreover, “Citramon-Darnitsa” won the title “Choice of the Year 2017” in the nomination for “The Medicine of the Year for Headache”, which fact confirms the trust and loyalty of consumers.
“Medichronal®-Darnitsa” became the leader among remedies for hangover both in volume and in money terms.
Medicinal products of the Pharmaceutical Firm Darnitsa in packs hold the top spot based on the results of sales in 2017 among medicines for sore throat in pills, ursodeoxycholic acids, ointments for wounds and nootropic drugs – those are “Septefrilum®-Darnitsa”, “Ursochol®”, “Oflocain-Darnitsa®” and “Neuro-Norm” accordingly.
Based on the results of sales in 2017, “Captopres-Dartnitsa” takes the lead in the category of antihypertensive products in money terms, “Tonorma®#30” holds the first place in the category of betablockers and calcium antagonists, “Metamax” is the leader among Meldonium products for cardio and neuropotency.
The categories, in which medicinal products manufactured by Darnitsa take the lead, confirm once again that the strategy chosen by the company, aimed at solving of significant health problems in cardiology, neurology and pain problems, is right.
It will be recalled that in 2017 the Pharmaceutical Firm Darnitsa set the National Record of the greatest number of sold medicinal products in the form of pills within the year 2016 – their quantity amounted to 121 million 578 thousand 463 packs. (According to the retail audit of the Market Research System of “Proxima Research” LLC).